News
This was the stock's second consecutive day of losses.
Despite a rocky Q1 start to 2025 with a 4.3% market drop, AbbVie managed to thrive amid economic unease and shifting investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback